These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6148236)

  • 1. Release of an active sodium transport inhibitor (ASTI) from rat hypothalamic cells in culture.
    Morgan K; Foord SM; Spurlock G; Charalambous BM; Dieguez C; Scanlon MF; Mir MA
    Endocrinology; 1984 Oct; 115(4):1642-4. PubMed ID: 6148236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An active sodium transport inhibitor released from spontaneously hypertensive and normotensive rat fetal hypothalamic cells in culture.
    Kendall JM; Thomas SE; Spurlock G; Mir MA
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):83S-87S. PubMed ID: 2843202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte sodium content, sodium transport, ouabain binding capacity and Na+, K+-ATPase activity in lean and obese subjects.
    Hawkins M; Whittaker J; Wales JK; Swaminathan R
    Horm Metab Res; 1984 Jun; 16(6):282-5. PubMed ID: 6094324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of a sodium transport inhibitor (inhibitin) from cultured human cancer cells.
    Morgan K; Spurlock G; Brown RC; Mir MA
    Cancer Res; 1986 Dec; 46(12 Pt 1):6095-100. PubMed ID: 3465434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium retention and increased vascular reactivity caused by a hypothalamic sodium transport inhibitor.
    Mir MA; Morgan K; Chappell S; Lewis M; Spurlock G; Collins P; Collins P; Lewis M; Scanlon M
    Clin Sci (Lond); 1988 Aug; 75(2):197-202. PubMed ID: 3409635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and partial purification of the sodium-potassium-ATPase inhibitor released from cultured rat hypothalamic cells.
    Morgan K; Lewis MD; Spurlock G; Collins PA; Foord SM; Southgate K; Scanlon MF; Mir MA
    J Biol Chem; 1985 Nov; 260(25):13595-600. PubMed ID: 2997173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of sodium transport in pig (Sus scrofa) erythrocytes.
    Whittaker J; Hawkins M; Swaminathan R
    Biochem Med; 1983 Aug; 30(1):43-8. PubMed ID: 6312975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ouabain binding and cation transport in human erythrocytes.
    Gardner JD; Kiino DR
    J Clin Invest; 1973 Aug; 52(8):1845-51. PubMed ID: 4719666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium transport inhibitor from bovine hypothalamus.
    Haupert GT; Sancho JM
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4658-60. PubMed ID: 228304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane events and ionic processes involved in dopamine release from tuberoinfundibular neurons. I. Effect of the inhibition of the Na+,K+-adenosine triphosphatase pump by ouabain.
    Taglialatela M; Amoroso S; Kaparos G; Maurano F; Di Renzo GF; Annunziato L
    J Pharmacol Exp Ther; 1988 Aug; 246(2):682-8. PubMed ID: 2457079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the mechanism of shrinkage-induced potassium influx in rat and human erythrocytes.
    Orlov SN; Pokudin NI; Gurlo TG; Okun IM; Aksentsev SL; Konev SV
    Gen Physiol Biophys; 1991 Aug; 10(4):359-71. PubMed ID: 1663056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of (Na+K+)-ATPase and cation transport by an antibody against renal plasma membranes.
    Ebel H; Aulbert E; Averdunk R
    Curr Probl Clin Biochem; 1977 Oct 23-26; 8():150-8. PubMed ID: 210995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Na(+)-Ca2+ exchange activity in central nerve endings. II. Relationship between pharmacological blockade by amiloride analogues and dopamine release from tuberoinfundibular hypothalamic neurons.
    Taglialatela M; Canzoniero LM; Cragoe EJ; Di Renzo G; Annunziato L
    Mol Pharmacol; 1990 Sep; 38(3):393-400. PubMed ID: 2402228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute serum depletion on Na+-K+ homeostasis in cultured human skin fibroblasts.
    Hopp L; Kuriyama S; Kino M; Aviv A
    J Cell Physiol; 1987 Jun; 131(3):318-29. PubMed ID: 3036886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Captopril inhibits ouabain-sensitive Na+/K+-ATPase.
    Accetto R; Rinaldi G; Weder AB
    Clin Physiol Biochem; 1989; 7(2):101-8. PubMed ID: 2547542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular sodium, potassium and magnesium concentration, ouabain-sensitive 86rubidium-uptake and sodium-efflux and Na+, K+-cotransport activity in erythrocytes of normal male subjects studied on two occasions.
    Lijnen P; Hespel P; Lommelen G; Laermans M; M'Buyamba-Kabangu JR; Amery A
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):525-33. PubMed ID: 3773597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hypokalaemia on the ouabain-sensitive sodium transport and the ouabain-binding capacity in human erythrocytes.
    Rubython EJ; Morgan DB
    Clin Sci (Lond); 1983 Feb; 64(2):177-82. PubMed ID: 6822054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual variability in membrane sodium transport during salt loading--evidence against the production of a Na+-K+-ATPase inhibitor in hypertension.
    Maling TJ; Siebers RW
    Prog Biochem Pharmacol; 1988; 23():91-100. PubMed ID: 2847194
    [No Abstract]   [Full Text] [Related]  

  • 19. A passive sodium transport inhibitory factor (inhibitin) released from leukaemic promyelocytes in culture.
    Morgan K; Mir MA
    Clin Sci (Lond); 1984 Mar; 66(3):365-8. PubMed ID: 6581886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitin: a specific inhibitor of sodium/sodium exchange in erythrocytes.
    Morgan K; Brown RC; Spurlock G; Southgate K; Mir MA
    J Clin Invest; 1986 Feb; 77(2):538-44. PubMed ID: 2418064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.